Roles of enhancer of zeste homolog 2: From skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis
暂无分享,去创建一个
[1] R. Boldrini,et al. The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx) , 2014, Oncogene.
[2] E. Hatzimichael,et al. Non‐coding RNAs and EZH2 interactions in cancer: Long and short tales from the transcriptome , 2013, International journal of cancer.
[3] E. Knudsen,et al. EZH2 and ALDH1 expression in ductal carcinoma in situ: Complex association with recurrence and progression to invasive breast cancer , 2013, Cell cycle.
[4] D. Speicher,et al. Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition , 2013, Cell cycle.
[5] Jindan Yu,et al. BRCA1 is a negative modulator of the PRC2 complex , 2013, The EMBO journal.
[6] Tim J. Wigle,et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2 , 2013, Proceedings of the National Academy of Sciences.
[7] L. Bagella,et al. Role of Enhancer of Zeste Homolog 2 Polycomb Protein and Its Significance in Tumor Progression and Cell Differentiation , 2013 .
[8] V. Sartorelli,et al. The histone chaperone Spt6 coordinates histone H3K27 demethylation and myogenesis , 2013, The EMBO journal.
[9] M. Hung,et al. Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke , 2013, EMBO molecular medicine.
[10] A. Giordano,et al. Activation and function of murine Cyclin T2A and Cyclin T2B during skeletal muscle differentiation , 2013, Journal of cellular biochemistry.
[11] A. Giordano,et al. On the role of retinoblastoma family proteins in the establishment and maintenance of the epigenetic landscape , 2013, Journal of cellular physiology.
[12] G. Perini,et al. Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma , 2013, The Journal of Biological Chemistry.
[13] Zhaohui S. Qin,et al. Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer. , 2013, Molecular cell.
[14] M. Bollen,et al. NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes , 2012, Nucleic acids research.
[15] P. Atadja,et al. Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation , 2012, Proceedings of the National Academy of Sciences.
[16] M. Nishimura,et al. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. , 2012, Lung cancer.
[17] Tim J. Wigle,et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. , 2012, Nature chemical biology.
[18] A. Giordano,et al. The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation , 2012, Cell cycle.
[19] Yan Liu,et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations , 2012, Nature.
[20] Q. Han,et al. Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia , 2012, Experimental biology and medicine.
[21] M. Vetter,et al. PRC2 during vertebrate organogenesis: a complex in transition. , 2012, Developmental biology.
[22] C. Creighton,et al. Pregnancy-Induced Noncoding RNA (PINC) Associates with Polycomb Repressive Complex 2 and Regulates Mammary Epithelial Differentiation , 2012, PLoS genetics.
[23] M. Kool,et al. EZH2-Regulated DAB2IP Is a Medulloblastoma Tumor Suppressor and a Positive Marker for Survival , 2012, Clinical Cancer Research.
[24] Zizhen Yao,et al. Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas , 2012, Epigenetics.
[25] Shadan Ali,et al. Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM , 2012, PloS one.
[26] A. Fusco,et al. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. , 2012, The Journal of clinical endocrinology and metabolism.
[27] R. Schwartz,et al. Conditional Ablation of Ezh2 in Murine Hearts Reveals Its Essential Roles in Endocardial Cushion Formation, Cardiomyocyte Proliferation and Survival , 2012, PloS one.
[28] A. Zannettino,et al. Twist-1 Induces Ezh2 Recruitment Regulating Histone Methylation along the Ink4A/Arf Locus in Mesenchymal Stem Cells , 2012, Molecular and Cellular Biology.
[29] V. Sartorelli,et al. Polycomb protein Ezh1 promotes RNA polymerase II elongation. , 2012, Molecular cell.
[30] Kiran C. Bobba,et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.
[31] S. Oliviero,et al. Myc Regulates the Transcription of the PRC2 Gene To Control the Expression of Developmental Genes in Embryonic Stem Cells , 2011, Molecular and Cellular Biology.
[32] J. Seidman,et al. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis , 2011, Nature Genetics.
[33] F. Chang,et al. 16-hydroxycleroda-3,13-dien-15,16-olide regulates the expression of histone-modifying enzymes PRC2 complex and induces apoptosis in CML K562 cells. , 2011, Life sciences.
[34] Katrina Tatton-Brown,et al. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height , 2011, Oncotarget.
[35] P. Guglielmelli,et al. EZH2 mutational status predicts poor survival in myelofibrosis. , 2011, Blood.
[36] R. Eckert,et al. (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells. , 2011, Carcinogenesis.
[37] D. Schwarzer,et al. Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells , 2011, Epigenetics & Chromatin.
[38] A. D. De Marzo,et al. Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms , 2011, Oncotarget.
[39] L. D. Croce,et al. Roles of the Polycomb group proteins in stem cells and cancer , 2011, Cell Death and Disease.
[40] D. Neuberg,et al. Clinical effect of point mutations in myelodysplastic syndromes. , 2011, The New England journal of medicine.
[41] M. Rudnicki,et al. Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells. , 2011, Genes & development.
[42] T. Hornyak,et al. EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/CDKN1A Expression , 2011, Molecular Cancer Research.
[43] P. L. Puri,et al. Phosphoryl-EZH-ion. , 2011, Cell stem cell.
[44] Haojie Huang,et al. Phosphorylation of EZH2 by CDK1 and CDK2 , 2011, Cell cycle.
[45] F. Sher,et al. Ezh2 expression in astrocytes induces their dedifferentiation toward neural stem cells. , 2011, Cellular reprogramming.
[46] D. Reinberg,et al. The Polycomb complex PRC2 and its mark in life , 2011, Nature.
[47] P. L. Puri,et al. Selective control of Pax7 expression by TNF-activated p38α/polycomb repressive complex 2 (PRC2) signaling during muscle satellite cell differentiation , 2011, Cell cycle.
[48] D. Reinberg,et al. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. , 2010, Genes & development.
[49] R. Copeland,et al. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas , 2010, Proceedings of the National Academy of Sciences.
[50] Lu Gan,et al. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2 , 2010, Nature Cell Biology.
[51] Valentina Proserpio,et al. TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. , 2010, Cell stem cell.
[52] A. Jankowska,et al. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies , 2010, Leukemia.
[53] L. Boyer,et al. Polycomb group proteins set the stage for early lineage commitment. , 2010, Cell stem cell.
[54] A. Tarakhovsky,et al. Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex , 2010, Proceedings of the National Academy of Sciences.
[55] H. Drexler,et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders , 2010, Nature Genetics.
[56] R. Kuiper,et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes , 2010, Nature Genetics.
[57] M. Bollen,et al. The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets , 2010, Nucleic Acids Research.
[58] K. Helin,et al. Polycomb group protein-mediated repression of transcription. , 2010, Trends in biochemical sciences.
[59] A. Iwama,et al. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells. , 2010, Journal of hepatology.
[60] Wendy A Bickmore,et al. Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. , 2010, Molecular cell.
[61] Qiang Yu,et al. Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression , 2010, Cell Death and Differentiation.
[62] Ji-Eun Lee,et al. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis , 2010, Proceedings of the National Academy of Sciences.
[63] C. Palii,et al. UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis , 2010, The EMBO journal.
[64] Juri Rappsilber,et al. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells , 2010, Nature.
[65] M. Jaritz,et al. Polycomb complexes act redundantly to repress genomic repeats and genes. , 2010, Genes & development.
[66] Gang Li,et al. Jarid2 and PRC2, partners in regulating gene expression. , 2010, Genes & development.
[67] S. Orkin,et al. Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem Cells , 2009, Cell.
[68] Arend Sidow,et al. Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells , 2009, Cell.
[69] T. Kerppola. Polycomb group complexes--many combinations, many functions. , 2009, Trends in cell biology.
[70] Giacomo Cavalli,et al. Recruitment of Polycomb group complexes and their role in the dynamic regulation of cell fate choice , 2009, Development.
[71] Kristian Helin,et al. Polycomb group proteins: navigators of lineage pathways led astray in cancer , 2009, Nature Reviews Cancer.
[72] D. Reinberg,et al. Role of the polycomb protein EED in the propagation of repressive histone marks , 2009, Nature.
[73] Robert E. Kingston,et al. Mechanisms of Polycomb gene silencing: knowns and unknowns , 2009, Nature Reviews Molecular Cell Biology.
[74] R. Young,et al. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. , 2009, Molecular cell.
[75] M. Vidal,et al. Polycomb Limits the Neurogenic Competence of Neural Precursor Cells to Promote Astrogenic Fate Transition , 2009, Neuron.
[76] J. Rinn,et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression , 2009, Proceedings of the National Academy of Sciences.
[77] A. Tarakhovsky,et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. , 2009, Genes & development.
[78] A. Bhushan,et al. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. , 2009, Genes & development.
[79] G. Hannon,et al. Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells , 2009, Cell.
[80] A. Probst,et al. Epigenetic inheritance during the cell cycle , 2009, Nature Reviews Molecular Cell Biology.
[81] A. Donfrancesco,et al. Deregulated expression of miR-26a and Ezh2 in Rhabdomyosarcoma , 2009, Cell cycle.
[82] Julien Gagneur,et al. Dynamic regulation by polycomb group protein complexes controls pattern formation and the cell cycle in Drosophila. , 2008, Developmental cell.
[83] J. Simon,et al. Roles of the EZH2 histone methyltransferase in cancer epigenetics. , 2008, Mutation research.
[84] D. Reinberg,et al. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. , 2008, Molecular cell.
[85] Guo-Cheng Yuan,et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. , 2008, Molecular cell.
[86] Huating Wang,et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. , 2008, Cancer cell.
[87] V. Balasubramaniyan,et al. Differentiation of Neural Stem Cells into Oligodendrocytes: Involvement of the Polycomb Group Protein Ezh2 , 2008, Stem cells.
[88] Simon Kasif,et al. Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains , 2008, PLoS genetics.
[89] K. Helin,et al. The Polycomb Repressive Complex 2 Is a Potential Target of SUMO Modifications , 2008, PloS one.
[90] Chung F. Wong,et al. MicroRNA-26a Targets the Histone Methyltransferase Enhancer of Zeste homolog 2 during Myogenesis* , 2008, Journal of Biological Chemistry.
[91] M. van Lohuizen,et al. Stem cell regulation by polycomb repressors: postponing commitment. , 2008, Current opinion in cell biology.
[92] D. Reinberg,et al. Ezh2 Requires PHF1 To Efficiently Catalyze H3 Lysine 27 Trimethylation In Vivo , 2008, Molecular and Cellular Biology.
[93] L. Bagella,et al. Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements , 2008, Journal of cellular physiology.
[94] M. Rudnicki,et al. Niche regulation of muscle satellite cell self-renewal and differentiation. , 2008, Cell stem cell.
[95] Hengbin Wang,et al. Role of hPHF1 in H3K27 Methylation and Hox Gene Silencing , 2007, Molecular and Cellular Biology.
[96] W. Webb,et al. P-TEFb Is Critical for the Maturation of RNA Polymerase II into Productive Elongation In Vivo , 2007, Molecular and Cellular Biology.
[97] T. Veenstra,et al. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases , 2007, Proceedings of the National Academy of Sciences.
[98] Min Gyu Lee,et al. Demethylation of H3K27 Regulates Polycomb Recruitment and H2A Ubiquitination , 2007, Science.
[99] I. Issaeva,et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development , 2007, Nature.
[100] Howard Y. Chang,et al. A histone H3 lysine 27 demethylase regulates animal posterior development , 2007, Nature.
[101] Howard Y. Chang,et al. Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.
[102] M. Buckingham. Skeletal muscle progenitor cells and the role of Pax genes. , 2007, Comptes rendus biologies.
[103] S. Berger. The complex language of chromatin regulation during transcription , 2007, Nature.
[104] Qiang Yu,et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. , 2007, Genes & development.
[105] Huating Wang,et al. NF-κB Regulation of YY1 Inhibits Skeletal Myogenesis through Transcriptional Silencing of Myofibrillar Genes , 2007, Molecular and Cellular Biology.
[106] M. Fraga,et al. The Polycomb group protein EZH2 directly controls DNA methylation , 2007, Nature.
[107] M. Esteller. Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.
[108] K. Helin,et al. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A‐ARF locus , 2007, The EMBO journal.
[109] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[110] R. Paro,et al. Polycomb/Trithorax response elements and epigenetic memory of cell identity , 2007, Development.
[111] Anke Sparmann,et al. Polycomb silencers control cell fate, development and cancer , 2006, Nature Reviews Cancer.
[112] Jürg Müller,et al. Polycomb response elements and targeting of Polycomb group proteins in Drosophila. , 2006, Current opinion in genetics & development.
[113] G. Peters,et al. Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.
[114] Henriette O'Geen,et al. Suz12 binds to silenced regions of the genome in a cell-type-specific manner. , 2006, Genome research.
[115] J. Zeitlinger,et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells , 2006, Nature.
[116] Kristian Helin,et al. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. , 2006, Genes & development.
[117] Megan F. Cole,et al. Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.
[118] B. Steensel,et al. Genome-wide profiling of PRC1 and PRC2 Polycomb chromatin binding in Drosophila melanogaster , 2006, Nature Genetics.
[119] Michel Bellis,et al. Chromosomal Distribution of PcG Proteins during Drosophila Development , 2006, PLoS biology.
[120] Richard Bourgon,et al. Genome-wide analysis of Polycomb targets in Drosophila melanogaster , 2006, Nature Genetics.
[121] A. Giordano,et al. MyoD recruits the cdk9/cyclin T2 complex on Myogenic‐genes regulatory regions , 2006, Journal of cellular physiology.
[122] Yi Zhang,et al. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. , 2005, Molecular cell.
[123] M. Hung,et al. Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3 , 2005, Science.
[124] Charlotte Collins,et al. Direct Isolation of Satellite Cells for Skeletal Muscle Regeneration , 2005, Science.
[125] A. Petrie,et al. Stem Cell Function, Self-Renewal, and Behavioral Heterogeneity of Cells from the Adult Muscle Satellite Cell Niche , 2005, Cell.
[126] S. Horvath,et al. Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.
[127] Y. Arsenijévic,et al. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. , 2005, Genes & development.
[128] J. Hsieh,et al. Down-regulation of Human DAB2IP Gene Expression Mediated by Polycomb Ezh2 Complex and Histone Deacetylase in Prostate Cancer* , 2005, Journal of Biological Chemistry.
[129] M. Fraga,et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.
[130] R. Kingston,et al. Chromatin Compaction by a Polycomb Group Protein Complex , 2004, Science.
[131] I. Weissman,et al. Isolation of Adult Mouse Myogenic Progenitors Functional Heterogeneity of Cells within and Engrafting Skeletal Muscle , 2004, Cell.
[132] G. Lyons,et al. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. , 2004, Genes & development.
[133] Yi Zhang,et al. Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes , 2004, Nature Genetics.
[134] T. Braun,et al. Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification , 2004, The EMBO journal.
[135] Yi Zhang,et al. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. , 2004, Molecular cell.
[136] D. Reinberg,et al. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. , 2004, Genes & development.
[137] C. Simone,et al. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci , 2004, Nature Genetics.
[138] Yi Zhang,et al. Hierarchical recruitment of polycomb group silencing complexes. , 2004, Molecular cell.
[139] M. Lohuizen,et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas , 2004, Nature.
[140] K. Helin,et al. Polycomb Group Proteins in Cell Cycle Progression and Cancer , 2004, Cell cycle.
[141] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[142] M. King,et al. Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.
[143] Kristian Helin,et al. EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.
[144] M Malone,et al. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas , 2003, Journal of clinical pathology.
[145] Hengbin Wang,et al. Role of Histone H3 Lysine 27 Methylation in X Inactivation , 2003, Science.
[146] L. Speybroeck. From Epigenesis to Epigenetics , 2002 .
[147] D. Reinberg,et al. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. , 2002, Genes & development.
[148] V. Pirrotta,et al. Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites , 2002, Cell.
[149] Brigitte Wild,et al. Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex , 2002, Cell.
[150] Hengbin Wang,et al. Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.
[151] M. Rudnicki,et al. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. , 2002, Molecular cell.
[152] F. Christians,et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. , 2001, Genes & development.
[153] P. L. Puri,et al. Regulation of muscle regulatory factors by DNA‐binding, interacting proteins, and post‐transcriptional modifications , 2000, Journal of cellular physiology.
[154] M. Rudnicki,et al. Pax7 Is Required for the Specification of Myogenic Satellite Cells , 2000, Cell.
[155] A. Otte,et al. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation , 1999, Nature Genetics.
[156] A. Pappo,et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[157] G. Merlino,et al. Rhabdomyosarcoma – working out the pathways , 1999, Oncogene.
[158] R. Kingston,et al. Stabilization of Chromatin Structure by PRC1, a Polycomb Complex , 1999, Cell.
[159] S. Tapscott,et al. Inactivation of MyoD-mediated expression of p21 in tumor cell lines. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[160] M. King,et al. Characterization of EZH1, a human homolog of Drosophila Enhancer of zeste near BRCA1. , 1996, Genomics.
[161] Herbert Waldmann,et al. Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA 1 and BRCA 2 , 2015 .
[162] S. Spunt,et al. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle. , 2011, Current topics in developmental biology.
[163] M. Hung,et al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells , 2011, Nature Cell Biology.
[164] A. Feinberg,et al. The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.
[165] P. Muñoz-Cánoves,et al. Regulation of skeletal muscle gene expression by p38 MAP kinases. , 2006, Trends in cell biology.
[166] D. Beach,et al. Polycomb CBX7 has a unifying role in cellular lifespan , 2004, Nature Cell Biology.
[167] Linda Van Speybroeck. From epigenesis to epigenetics: the case of C. H. Waddington. , 2002, Annals of the New York Academy of Sciences.